Obalon Therapeutics Inc. (OBLN)
Symbol Info
Listed Symbol OBLN
Name Obalon Therapeutics Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $9,101,000
Latest Fiscal EPS $-19.90
Price Info
21 Day Moving Average $4.5043
21 Day EMA $4.036530
50 Day Moving Average $6.0553
50 Day EMA $5.586550
200 Day EMA $13.029480
200 Day Moving Average 12.675380
52 Week High $37.00
52 Week Low $2.26
52 Week Change $-85.764700
Alpha -0.000397
Beta -4.7154
Standard Deviation 0.424977
R2 0.161139
Periods 34
Share Information
10 Day Average Volume 427,849
20 Day Average Volume 814,568
30 Day Average Volume 589,247
50 Day Average Volume 468,635
Outstanding Shares 5,985,761
Float Shares 5,232,994
Percent Float 87.42%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 73
Institute Holdings Date 2019-07-31
Institute Bought Previous 3 Months 32,262
Institute Holdings Percent 24.000000
Institute Sold Previous 3 Months 195,872
Insider Holdings Date 2019-07-31
Insider Bought Previous 3 Months 12
Insider Holdings Percent 21.20%
Insider Sold Previous 3 Months -
Insiders Shares Owned 752,767
Price Change
7 Day Price Change $-0.5799999
7 Day Percent Change -19.33%
21 Day Price Change $-4.08
21 Day Percent Change -62.77%
30 Day Price Change $-3.829
30 Day Percent Change -61.27%
Month To Date Price Change $-2.78
Month To Date Percent -53.46%
90 Day Price Change $-1.875
90 Day Percent Change -43.66%
Quarter To Date $-4.571
Quarter To Date Percent -65.38%
180 Day Price Change $-18.28
180 Day Percent Change -88.31%
200 Day Price Change $-14.68
200 Day Percent Change -85.85%
Year To Date $-18.28
Year To Date Percent -88.31%
Profile
Description Obalon Therapeutics Inc is a medical device company that focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss.
Details
Issue Type CS
Market Cap $14,485,542
Sec Type EQS
Auditor KPMG LLP
Total Shares Outstanding 5,985,761
CEO
Employees 103
Last Audit UE
Classification
CIK 0001427570
Industry Medical Devices
Sector Healthcare
NAICS Surgical and Medical Instrument Manufacturing(339112)
Info
Address 5421 Avenida Encinas
Suite F
Carlsbad, CA 92008
Website http://www.obalon.com
Facisimile
Telephone +1 844 362-2566
Email wplovanic@obalon.com
Key Ratios
Profitability
EBIT Margin -414.9
EBITDA Margin -404.5
Pre-Tax Profit Margin -405.8
Profit Margin Cont -
Gross Margin 32.70
Profit Margin TOT -
Income Statements
Revenue $7,184,000
Revenue Per Share $1.2002
Revenue 3 Years $30.37
Revenue 5 Years $-
Valuation Measures
PE Ratio -
Enterprise Value $7,820,975
Price To Sales 2.016362
Price To Free Cash -0.6
PE High Last 5 Years -
Price To Book 1.8
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book 1.8
Financial Strength
Total Debt To Equity 0.7
Int Coverage -435.5
Current Ratio 1.7
Leverage Ratio 2.5
Quick Ratio 1.4
Long Term Debt To Capital 0.08
Assets
Receivables Turnover 1.1
Invoice Turnover 2.40
Assets Turnover 0.10
Management Effectiveness
Return Assets -118.28
Return On Equity -250.09
Return On Capital -150.63
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
OBLN
Obalon The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.